Actively Recruiting
Optical Coherence Tomography for Intracranial Atherosclerotic Stenosis
Led by jiaoliqun · Updated on 2022-09-23
400
Participants Needed
1
Research Sites
406 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To evaluate the clinical significance of optical coherence tomography (OCT) in interventional treatment of intracranial atherosclerotic stenosis (ICAS).
CONDITIONS
Official Title
Optical Coherence Tomography for Intracranial Atherosclerotic Stenosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Symptomatic intracranial atherosclerotic stenosis (ICAS) with a transient ischemic attack or stroke related to the affected artery
- Narrowing of 50% or more in at least one major intracranial artery (internal carotid, vertebral, middle cerebral, or basilar artery) measured by digital subtraction angiography
You will not qualify if you...
- Presence of arteriovenous malformation
- Presence of an aneurysm
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Xuanwu Hospital, Capital Medical University
Beijing, Beijing Municipality, China, 100005
Actively Recruiting
Research Team
L
Liqun Jiao, Professor
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here